Trials / Completed
CompletedNCT03354910
House Calls and Peer Mentorship
Comparing the Effectiveness of House Calls and Peer Mentorship to Reduce Racial Disparities in Live Donor Kidney Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 320 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Live donor kidney transplantation (LDKT) offers the most optimal survival and quality of life benefit for those with late-stage chronic kidney disease. However, minorities, especially blacks, are much less likely to receive LDKT than whites. Given the shortage of deceased donor organs, interventions expanding access to LDKT are needed, particularly for minority patients. House Calls (HC), an educational intervention developed by this study's PI has been shown to be an effective program for raising rates of live donation, especially for black patients. While the HC program has shown outstanding results, participant feedback suggested that follow-up may provide even more benefits. Previous research suggests that peer mentorship (PM) from former or current patients with ESRD may be effective in raising rates of living donation. As such, peer mentorship programs may act as an effective follow-up for HC participants. This study will examine the impact of the HC intervention combined with the peer mentorship program of the National Kidney Foundation on rates of live donor kidney transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | House Call | 60 to 90 minute home based educational intervention which will be administered by a health educator. |
| BEHAVIORAL | Peer Mentorship | A National Kidney Foundation Peer Mentor will be assigned to the participant to provide contact and support to study participants. |
Timeline
- Start date
- 2018-04-30
- Primary completion
- 2021-03-31
- Completion
- 2022-12-18
- First posted
- 2017-11-28
- Last updated
- 2024-03-18
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03354910. Inclusion in this directory is not an endorsement.